Cerenome (CNSY) executive compensation, 2025 proxy

Marc H. Hedrick, M.D., President and Chief Executive Officer, was paid $1.3M in 2024, up 11% from $1.1M the year before.

Filed
July 21, 2025
Annual meeting
August 7, 2025
Pay year
2024
Named executives
3
CEO total pay
$1.3M+11% vs prior year
CEO target bonus
55%Of base salary
Corporate goal achievement
105%2024 performance
CFO total compensation
$621,116
CEO option shares
291,607Granted during 2024
CFO option shares
65,007Granted during 2024
Former CMO total pay
$285,9122024 compensation

How M.D. was paid

$1.3M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary44%Option awards27%Non-equity incentive25%All other compensation4%

Named executive officers

ExecutiveTotal
Marc H. Hedrick, M.D.President and Chief Executive Officer$1,260,285
Andrew SimsChief Financial Officer$621,116
Norman LaFrance, M.D.Former Chief Medical Officer$285,912

What changed and why

  • $1.3M$1,260,285 CEO total compensation increased from $1,134,027 in 2023.
  • $335K$335,348 CEO option awards increased from $188,692 in 2023.
  • 105%105% corporate-goal achievement produced the CEO’s $321,321 performance bonus.
  • 55%55% CEO target bonus remained tied entirely to corporate objectives.
  • 105%$156,555 CFO incentive compensation reflected 105% corporate and individual goal attainment.
  • Norman LaFrance stepped down as Chief Medical Officer on June 11, 2024.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.